Single answer
Is Abbott Laboratories (ABT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Abbott Laboratories is $134.64, which is $21.05 (18.53%) above the current price today's price.
Low target: $120.00 | High target: $152.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Abbott Laboratories together with its subsidiaries discovers develops manufactures and sells health care products worldwide It operates in four segments Established Pharmaceutical Products Diagnostic Products Nutritional Products and Medical Devices The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency irritable bowel syndrome or biliary spasm intrahepatic cholestasis or depressive symptoms gynecological disorder hormone replacement therapy dyslipidemia hypertension hypothyroidism Menieres disease and vestibular vertigo pain fever inflammation and migraine as well as provides antiinfective clarithromycin influenza vaccine and products to regulate physiological rhythm of the colon The Diagnostic Products segment offers laboratory systems in the areas of immunoassay clinical chemistry hematology and transfusion molecular diagnostics systems that automate the extraction purification and preparation of DNA and RNA from patient samples as well as detect and measure infectious agents point of care systems cartridges for testing blood rapid diagnostics lateral flow testing products molecular pointofcare testing for HIV SARSCoV2 influenza A and B RSV and strep A cardiometabolic test systems drug and alcohol test and remote patient monitoring and consumer selftest systems and informatics and automation solutions for use in laboratories The Nutritional Products segment provides pediatric and adult nutritional products The Medical Devices segment offers rhythm management electrophysiology heart failure vascular and structural heart devices for the treatment of cardiovascular diseases and diabetes care products as well as neuromodulation devices for the management of chronic pain and movement disorders Abbott Laboratories was founded in 1888 and is based in North Chicago Illinois
Website: https://www.abbott.com
Rates and inflation backdrop
US inflation for December 2025 was 0.31%. Over the last 12 months, inflation is 3.03%. The 10-year yield is 4.16 and is up 0.120 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.15. Cash flow to debt ratio: 0.70. Net profit margin: 14.72%. Inflation risk score: low (0.25/1).
Dividend history check
Yes, Abbott Laboratories pays dividends. Last payment was 2026-02-13 for holders on 2026-01-15. Over 175 payments between 1983 and 2026, total $56.08 with an average of $0.320 per share. Last dividend was $0.630.
Trading liquidity
Yes, the average daily trading liquidity for Abbott Laboratories is $952.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Abbott Laboratories, 2016-02-12 had a stock price of $37.13. If you invested back then, your return now would be a profit of $76.46 per share or 205.93%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.